Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
88195
Created by
admin on Sat Dec 16 08:35:03 GMT 2023 , Edited by admin on Sat Dec 16 08:35:03 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000175148
Created by
admin on Sat Dec 16 08:35:03 GMT 2023 , Edited by admin on Sat Dec 16 08:35:03 GMT 2023
|
PRIMARY | |||
|
CD-157
Created by
admin on Sat Dec 16 08:35:03 GMT 2023 , Edited by admin on Sat Dec 16 08:35:03 GMT 2023
|
PRIMARY | |||
|
9875
Created by
admin on Sat Dec 16 08:35:03 GMT 2023 , Edited by admin on Sat Dec 16 08:35:03 GMT 2023
|
PRIMARY | |||
|
C174744
Created by
admin on Sat Dec 16 08:35:03 GMT 2023 , Edited by admin on Sat Dec 16 08:35:03 GMT 2023
|
PRIMARY | |||
|
N6UAH27EUV
Created by
admin on Sat Dec 16 08:35:03 GMT 2023 , Edited by admin on Sat Dec 16 08:35:03 GMT 2023
|
PRIMARY | |||
|
2046361
Created by
admin on Sat Dec 16 08:35:03 GMT 2023 , Edited by admin on Sat Dec 16 08:35:03 GMT 2023
|
ALTERNATIVE | |||
|
Pegvaliase
Created by
admin on Sat Dec 16 08:35:03 GMT 2023 , Edited by admin on Sat Dec 16 08:35:03 GMT 2023
|
PRIMARY | |||
|
5340
Created by
admin on Sat Dec 16 08:35:03 GMT 2023 , Edited by admin on Sat Dec 16 08:35:03 GMT 2023
|
PRIMARY | |||
|
2046360
Created by
admin on Sat Dec 16 08:35:03 GMT 2023 , Edited by admin on Sat Dec 16 08:35:03 GMT 2023
|
PRIMARY | |||
|
DB12839
Created by
admin on Sat Dec 16 08:35:03 GMT 2023 , Edited by admin on Sat Dec 16 08:35:03 GMT 2023
|
PRIMARY | |||
|
N6UAH27EUV
Created by
admin on Sat Dec 16 08:35:03 GMT 2023 , Edited by admin on Sat Dec 16 08:35:03 GMT 2023
|
PRIMARY | |||
|
1585984-95-7
Created by
admin on Sat Dec 16 08:35:03 GMT 2023 , Edited by admin on Sat Dec 16 08:35:03 GMT 2023
|
PRIMARY |
ACTIVE MOIETY